PITX2 rs67249485 and age, not the postoperative inflammatory response, predict new-onset atrial fibrillation after cardiac surgery with cardiopulmonary bypass: a prospective genotyped cohort study (INFLACOR)

When the heart is stopped and restarted during open-heart surgery, the body often reacts with a surge of inflammation, a natural defense mechanism that can sometimes go too far. For decades, doctors have suspected that this inflammatory storm is the primary reason why many patients develop a new, irregular heartbeat called atrial fibrillation shortly after their operation. This condition, where the heart's upper chambers quiver instead of beating steadily, is the most common complication of cardiac surgery. It can prolong hospital stays, increase the risk of stroke, and complicate recovery. The prevailing theory was that the more intense the body's inflammatory response to the surgery, the higher the chance a patient would develop this dangerous rhythm. If this were true, then measuring inflammation levels after surgery could help doctors predict who would get sick and who would remain stable.

However, a recent study challenges this long-held belief by looking at the patient's own biology rather than just the surgery's aftermath. The researchers focused on two main possibilities: either the inflammation caused by the surgery triggers the irregular heartbeat, or the patient's genetic makeup and age make them inherently susceptible to it, regardless of how much inflammation is present. To find the answer, a team of scientists in Poland followed hundreds of patients undergoing heart surgery with a heart-lung machine, a procedure that temporarily takes over the work of the heart and lungs. They carefully tracked who developed the new irregular heartbeat and compared their blood test results, which measured inflammation, against their genetic code. The study aimed to see if the body's reaction to the operation was the deciding factor, or if the answer lay in the patient's constitution before they ever entered the operating room.

The study, known as INFLACOR, began in 2009 and followed 525 adults undergoing their first open-heart surgery. The researchers excluded anyone who already had a history of irregular heartbeats to ensure they were studying only new cases. Out of the 364 patients who had no prior heart rhythm issues, 115 developed a new episode of atrial fibrillation after the operation. The team had a specific plan to test the inflammation theory. They measured various markers in the blood on the first day after surgery, including proteins and cells that signal the body is fighting stress or injury. They also looked at ten specific genetic variations known to be linked to inflammation. If the inflammation theory were correct, the patients who developed the irregular heartbeat should have shown significantly higher levels of these inflammatory markers or specific genetic traits related to inflammation compared to those who did not.

The results were clear and surprising. The researchers found no link between the measured inflammatory response and the development of the new irregular heartbeat. The levels of inflammatory markers in the blood were similar for both groups, and the specific genes related to inflammation did not distinguish between those who got sick and those who recovered smoothly. Instead, the study pointed to two other factors that acted as the true predictors. The first was simply the patient's age; for every ten years a patient got older, their risk of developing the condition increased significantly. The second factor was a specific genetic variation found in a region of DNA called 4q25, near a gene named PITX2, which helps determine the structure of the left side of the heart. Patients who carried one copy of a specific version of this gene were nearly twice as likely to develop the irregular heartbeat compared to those who did not carry it.

When the researchers combined these two factors into a single model, they found that age and this specific genetic trait were the only independent predictors that mattered. The study suggests that the inflammation caused by the surgery is a universal event that happens to almost everyone, but it is not the deciding factor for who gets the irregular heartbeat. Rather, the risk is set by the patient's own biology before the surgery even begins. The heart of a patient with the specific genetic variation and advanced age appears to be more vulnerable to the stress of surgery, much like a dry forest is more likely to catch fire during a heatwave than a damp one, regardless of how hot the air gets. The study did not find that the inflammation itself caused the difference; instead, it found that the patient's inherent constitution determined who would succumb to the arrhythmia.

The study also looked at what happened to the patients after they developed the irregular heartbeat. Those who experienced the new condition were more likely to suffer from other serious complications in the days following surgery, such as acute respiratory failure, kidney injury, and delirium. The risk of developing delirium, a state of confusion and altered consciousness, was nearly five times higher in patients with the new irregular heartbeat. Despite these serious short-term complications, the study found that the irregular heartbeat did not change the long-term survival rates. Patients who developed the condition were just as likely to be alive one year or five years later as those who did not, suggesting that while the condition signals a difficult recovery, it does not necessarily shorten life in the long run.

The researchers acknowledged that their study had some limitations. The group of patients was relatively small for a genetic study, and they only looked at four specific genetic variations related to heart rhythm, rather than scanning the entire genome. They also noted that their definition of the irregular heartbeat required it to be significant enough to need medical treatment, which means they might have missed very brief episodes. Furthermore, the study was conducted in a single hospital in Poland, so the results need to be confirmed in other populations. Despite these caveats, the findings offer a new perspective on a common medical problem. By showing that the body's inflammatory response does not predict who will get the irregular heartbeat, the study shifts the focus away from trying to suppress inflammation after surgery and toward understanding the patient's underlying genetic and age-related risks.

In the end, the study concludes that the risk of developing a new irregular heartbeat after heart surgery is determined by who the patient is, not just by what happens to them during the operation. The inflammation that follows the procedure is a standard part of the healing process, but it is the patient's age and their specific genetic makeup that decide whether that stress will trigger a dangerous rhythm. This insight helps clarify why some patients struggle with this complication while others do not, suggesting that the answer lies in the patient's own biology rather than in the intensity of the surgical trauma. While the irregular heartbeat remains a serious warning sign of a difficult recovery, it appears to be a consequence of the patient's pre-existing vulnerability rather than a direct result of the inflammatory storm caused by the surgery.